Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation (Q33163052)

23 July 2017

Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation (English)

1 reference

23 July 2017

Andersen-Tawil syndrome

1 reference

11

0 references

Stéphane Bézieau

12

Stéphane Bézieau

0 references

Hervé Le Marec

14

Hervé Le Marec

1 reference

23 July 2017

Florence Kyndt

10

0 references

Vincent Probst

Vincent Probst

17

0 references

Philippe Maury

Philippe Maury

3

1 reference

ORCID Public Data File 2021

Frederic Sacher

2

Frédéric Sacher

1 reference

23 July 2017

4

Philippe Mabo

1 reference

23 July 2017

Eric Delannoy

1

1 reference

23 July 2017

Jacques Mansourati

5

1 reference

23 July 2017

Isabelle Magnin

6

1 reference

23 July 2017

Jean-Pierre Camous

7

1 reference

23 July 2017

Guillaume Tournant

8

1 reference

23 July 2017

Eric Rendu

9

1 reference

23 July 2017

Stéphane Bézieau

12

1 reference

23 July 2017

Béatrice Guyomarch

13

1 reference

23 July 2017

Véronique Fressart

15

1 reference

23 July 2017

Isabelle Denjoy

16

1 reference

23 July 2017

17 July 2013

1 reference

23 July 2017

1 reference

23 July 2017

15

1 reference

23 July 2017

1805-1811

1 reference

23 July 2017

12

1 reference

Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. A new syndrome?

23 July 2017

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT160

Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT160

PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT160

Amiodarone and acetazolamide for the treatment of genetically confirmed severe Andersen syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT160

Calcium channel blocker and adenosine triphosphate terminate bidirectional ventricular tachycardia in a patient with Andersen-Tawil syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT160

Flecainide for recurrent malignant ventricular arrhythmias in two siblings with Andersen-Tawil syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT160

Alterations in conserved Kir channel-PIP2 interactions underlie channelopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT160

Inwardly rectifying potassium channels: their structure, function, and physiological roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT160

Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT160

Andersen-Tawil syndrome: Prospective cohort analysis and expansion of the phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT160

Resuscitated sudden cardiac death in Andersen-Tawil syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT160

Sudden cardiac death in Andersen-Tawil syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT160

Oral verapamil effectively suppressed complex ventricular arrhythmias and unmasked U waves in a patient with Andersen-Tawil syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT160

Suppression of bidirectional ventricular tachycardia and unmasking of prolonged QT interval with verapamil in Andersen's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT160

Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT160

Polymorphic ventricular tachycardia and KCNJ2 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT160

Kir 2.1 channelopathies: the Andersen-Tawil syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT160

Differential distribution of inward rectifier potassium channel transcripts in human atrium versus ventricle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT160

IK1 modulates the U-wave: insights in a 100-year-old enigma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT160

Cellular basis for electrocardiographic and arrhythmic manifestations of Andersen-Tawil syndrome (LQT7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT160

21 January 2018

Identifiers

DOI

10.1093/EUROPACE/EUT160

1 reference

23 July 2017

1 reference